Literature DB >> 7836499

Fall conception increases the risk of neurodevelopmental disorder in offspring.

J Liederman1, K A Flannery.   

Abstract

Hormonal imbalances in utero may render males more vulnerable to neurodevelopmental disorder (ND) than females. Since hormonal activity can be influenced by photoperiod, the relationship between season of conception and incidence of ND in offspring was examined within 11,578 mother/child pairs. Fall conception significantly elevated the odds for mental retardation, reading, arithmetic disability, or performance aptitude deficits (but not seizures, articulation disorder, cerebral palsy, or verbal aptitude deficits), and decreased the odds for reading talent (even when socioeconomic class, prenatal visits, infections, fever, vomiting, edema, anemia, and weight loss were covaried). Since the seasonality effect was not stronger in males, and was not specific to those NDs caused by left hemisphere dysfunction, the predictions of Geschwind and Galaburda (1985a, 1985b, 1985c) were not confirmed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836499     DOI: 10.1080/01688639408402689

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  3 in total

1.  Season of birth: A predictor of ADHD symptoms in early midlife.

Authors:  Chenshu Zhang; Judith S Brook; Carl G Leukefeld; Mario De La Rosa; David W Brook
Journal:  Psychiatry Res       Date:  2018-06-06       Impact factor: 3.222

2.  Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children.

Authors:  Richard L Morrow; E Jane Garland; James M Wright; Malcolm Maclure; Suzanne Taylor; Colin R Dormuth
Journal:  CMAJ       Date:  2012-03-05       Impact factor: 8.262

3.  Month of birth and risk of autism spectrum disorder: a retrospective cohort of male children born in Israel.

Authors:  Hila Shalev; Ido Solt; Gabriel Chodick
Journal:  BMJ Open       Date:  2017-11-16       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.